Browsing by Subject "CB2R agonists"
Now showing items 1-1 of 1
-
(MDPI, 2021)The activation of the human cannabinoid receptor type II (CB2R) is known to mediate analgesic and anti-inflammatory processes without the central adverse effects related to cannabinoid receptor type I (CB1R). In this work ...